pentobarbital has been researched along with Wolfram Syndrome in 1 studies
Pentobarbital: A short-acting barbiturate that is effective as a sedative and hypnotic (but not as an anti-anxiety) agent and is usually given orally. It is prescribed more frequently for sleep induction than for sedation but, like similar agents, may lose its effectiveness by the second week of continued administration. (From AMA Drug Evaluations Annual, 1994, p236)
pentobarbital : A member of the class of barbiturates, the structure of which is that of barbituric acid substituted at C-5 by ethyl and sec-pentyl groups.
Wolfram Syndrome: A hereditary condition characterized by multiple symptoms including those of DIABETES INSIPIDUS; DIABETES MELLITUS; OPTIC ATROPHY; and DEAFNESS. This syndrome is also known as DIDMOAD (first letter of each word) and is usually associated with VASOPRESSIN deficiency. It is caused by mutations in gene WFS1 encoding wolframin, a 100-kDa transmembrane protein.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Raud, S | 1 |
| Reimets, R | 1 |
| Loomets, M | 1 |
| Sütt, S | 1 |
| Altpere, A | 1 |
| Visnapuu, T | 1 |
| Innos, J | 1 |
| Luuk, H | 1 |
| Plaas, M | 1 |
| Volke, V | 1 |
| Vasar, E | 1 |
1 other study available for pentobarbital and Wolfram Syndrome
| Article | Year |
|---|---|
Deletion of the Wolfram syndrome-related gene Wfs1 results in increased sensitivity to ethanol in female mice.
Topics: Animals; Anxiety; Central Nervous System Depressants; Dose-Response Relationship, Drug; Ethanol; Exp | 2015 |